May 17, 2020

Apollo Hospitals will support healthcare startups with signed MoU with IBM

healthcare services
healthcare services
Catherine Sturman
2 min
Apollo Hospitals (Getty Images)
Apollo Hospitals has recently signed a Memorandum of Understanding (MoU)to support the growing number of healthcare startups across India, The Financial...

Apollo Hospitals has recently signed a Memorandum of Understanding (MoU) to support the growing number of healthcare startups across India, The Financial Express has reported.

With a growing fund, rising from $50mn to $100mn, the country will initially provide $5mn, which will then rise to $10mn. Running an accelerator programme will therefore enable the company to further support the emerging number of healthtech companies.

Apollo Hospital’s partnership with IBM Watson Healthcare will also see the company further its work within artificial intelligence.

Joint Managing Director Sangita Reddy explained: “We have always believed in using technology and we were the pioneers in the orthopaedic space to use advanced technology. We were also the first to introduce robotic surgery.

“We are also going to work with IBM Watson Healthcare in the artificial intelligence space. We are collaborating with few more companies where we are going to share intellectual property rights (IPR).”

The fund will also enable the development of a new onco-diagnostics system.

See also

The company has also worked on providing exceptional healthcare training across India and Africa. Developing a specialised training programme for paramedical staff from nine African countries, Apollo Hospital has previously trained over 100 medical doctors from 24 African countries.

The move comes as the Ministry of External Affairs, Government of India and African national governments look to further deepen ties in capacity building and training of health workers in multiple African nations.

Dr Neena Malhotra, Joint Secretary (E&SA), Ministry of External Affairs, Government of India said, “The programme will help strengthen the health systems of participating nations and it was our endeavour to expand it to other healthcare professionals.

Dr K Hariprasad, President - Hospitals Division, Apollo Hospitals Group, said, "This training program highlights the further deepening of the ties between MEA, Apollo and African Governments to strengthen healthcare human resources in the continent.

“Our commitment to the continent to strengthen its health systems, provide medical care of highest quality and partner, shoulder to shoulder in the rise of Africa remains steadfast. We hope that the training provided will benefit the health system and nationals of the delegate countries."

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article